Search

In this annual report, we detail our progress in 2024-25 toward realizing that vision.

The Heart Institute's Board of Directors currently includes:

The University of Ottawa Heart Institute (UOHI) offers internationally recognized programs, education and services for the prevention and management of cardiovascular disease risk factors to patients, families, healthcare practitioners, and the public.

At any given time, the Heart Institute may have up to 200 active clinical trials, in various stages of the lifecycle of a study.

Working and studying at the Heart Institute can be immensely rewarding. This section provides information on employment and training opportunities relating to care, education and research at the Heart Institute.

Adult Cardiology Postgraduate Training Programs- Adult Cardiac Electrophysiology- New Program Director- Dr Simon Hansom @email Adult Interventional Cardiology New Program Director as well- remove Dr Alexander Dick- and his email and add Dr Zeeshan Ahmed @email

This unique approach uses small incisions between the ribs to access the heart as an alternative to the incision through the breastbone (sternum) typical of traditional open-heart surgery. As a result, there may be less damage to surrounding tissues and therefore less pain and quicker healing.

The Ottawa Heart Institute Research Corporation (OHIRC) Board of Directors currently includes:

The Ottawa Heart Institute is launching “One Million Canadian Hearts,” a pioneering initiative to screen one million Canadians for cardiovascular disease risk factors. By screening early, intervening swiftly, and harnessing powerful data insights, we will save lives and uncover the realities of heart disease—who is most at risk, what factors shape outcomes, and how we can intervene more effectively. This initiative will not only empower Canadians to protect their heart health but also fuel transformative research to redefine prevention, treatment, and care on a national scale.

Publications authored by Ottawa Heart Institute researchers and physicians in 2025.

Our 2025–2030 strategic plan represents more than a roadmap – it is a declaration of our steadfast dedication to pushing boundaries, embracing collaboration, and harnessing the power of cutting-edge technology and AI to address the evolving needs of patients, while never losing the human touch. It is a reaffirmation of our values and a bold vision for what is to come.